IRIS Accounts Production v24.3.2.46 09987941 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099879412023-03-31099879412024-03-31099879412023-04-012024-03-31099879412022-03-31099879412022-04-012023-03-31099879412023-03-3109987941ns15:EnglandWales2023-04-012024-03-3109987941ns14:PoundSterling2023-04-012024-03-3109987941ns10:Director12023-04-012024-03-3109987941ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3109987941ns10:SmallEntities2023-04-012024-03-3109987941ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3109987941ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3109987941ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3109987941ns10:FullAccounts2023-04-012024-03-3109987941ns10:OrdinaryShareClass12023-04-012024-03-3109987941ns10:Director22023-04-012024-03-3109987941ns10:RegisteredOffice2023-04-012024-03-3109987941ns5:CurrentFinancialInstruments2024-03-3109987941ns5:CurrentFinancialInstruments2023-03-3109987941ns5:ShareCapital2024-03-3109987941ns5:ShareCapital2023-03-3109987941ns5:RetainedEarningsAccumulatedLosses2024-03-3109987941ns5:RetainedEarningsAccumulatedLosses2023-03-3109987941ns5:CostValuation2023-03-3109987941ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109987941ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3109987941ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 09987941 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

ALPHA BIOLABORATORIES LIMITED

ALPHA BIOLABORATORIES LIMITED (REGISTERED NUMBER: 09987941)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ALPHA BIOLABORATORIES LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2024







DIRECTORS: Mr D Thomas
Ms R Thomas





REGISTERED OFFICE: 14 Webster Court
Carina Park
Westbrook
Warrington
WA5 8WD





REGISTERED NUMBER: 09987941 (England and Wales)





ACCOUNTANTS: Xeinadin
100 Barbirolli Square
Manchester
M2 3BD

ALPHA BIOLABORATORIES LIMITED (REGISTERED NUMBER: 09987941)

BALANCE SHEET
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Investments 4 100 100

CURRENT ASSETS
Debtors 5 163,875 164,474

CREDITORS
Amounts falling due within one year 6 200,680 201,279
NET CURRENT LIABILITIES (36,805 ) (36,805 )
TOTAL ASSETS LESS CURRENT LIABILITIES (36,705 ) (36,705 )

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings (36,707 ) (36,707 )
SHAREHOLDERS' FUNDS (36,705 ) (36,705 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 March 2025 and were signed on its behalf by:





Mr D Thomas - Director


ALPHA BIOLABORATORIES LIMITED (REGISTERED NUMBER: 09987941)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

Alpha Biolaboratories Limited is a private company limited by share capital,incorporated in England and Wales, registration number 09987941.The address of the registered office and principal place of business is Unit 14 Webster Court, Carina Park,Westbrook, Warrington WA5 8WD.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The concept of going concern is an underlying assumption in the production of financial statements. As there are net liabilities there is a question mark over going concern. Although there is no formal agreement in place the group directors have indicated that they will continue to provide financial support to the company for at least the next 12 months from the date of signing the directors report.

Preparation of consolidated financial statements
The financial statements contain information about Alpha Biolaboratories Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Investments in subsidiaries
Fixed assets investments are stated at cost less provision for impairment.

Other debtors
Other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, the receivables are stated at cost less impairment losses for bad and doubtful debts.

Other creditors
Other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case they are stated at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2023
and 31 March 2024 100
NET BOOK VALUE
At 31 March 2024 100
At 31 March 2023 100

ALPHA BIOLABORATORIES LIMITED (REGISTERED NUMBER: 09987941)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Amounts owed by group undertakings 156,631 -
Other debtors 7,244 164,474
163,875 164,474

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Amounts owed to group undertakings 130,680 -
Other creditors 70,000 201,279
200,680 201,279

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
2 Ordinary £1.00 2 2

During the year, the share capital of the company was acquired by Alpha Biolaboratories Holdings Limited by way of a share for share exchange.

8. RELATED PARTY DISCLOSURES

At the balance sheet date the company was owed £Nil (2023: £157,321) from companies under common control.

At the balance sheet date the company owed £70,000 (2023: £200,680) to companies under common control.

9. ULTIMATE CONTROLLING PARTY

The company's immediate parent entity is Alpha Biolaboratories Holdings Limited. The parent company's registered office is 14 Webster Court, Carina Park, Warrington, Cheshire, WA5 8WD.

The ultimate controlling party are the shareholders of the ultimate parent entity, Alpha Biolaboratories Holdings Limited.